Ebos Group Ltd

EBO: XNZE (NZL)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
NZD 94.50PrqkrcTvpydyhz

Ebos Earnings: Resilient Margins but Shares Are Expensive

Narrow-moat Ebos increased first-half fiscal 2024 revenue and underlying EBITDA by 7% and 8%, respectively, driven by creditable cost control and higher-margin medical technology. Group EBITDA margin expanded slightly by 5 basis points to 4.8% despite cost pressures in labor and freight.

Sponsor Center